# Ningxia Qiyuan Pharmaceutical Co., Ltd. – FDA Inspection, Jun 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/ningxia-qiyuan-pharmaceutical-co-ltd/eb30e7e5-bad4-4bb7-a57e-17a4d6867397
Source feed: FDA_Inspections

> FDA inspection 1097755 of Ningxia Qiyuan Pharmaceutical Co., Ltd., June 28, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097755
- Company Name: Ningxia Qiyuan Pharmaceutical Co., Ltd.
- Inspection Date: 2019-06-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1288410 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/ningxia-qiyuan-pharmaceutical-co-ltd/59d506fe-ce34-4446-82c1-d1ad672e327b)
- FDA Inspection 968192 - 2016-04-28
- FDA Inspection 901778 - 2014-09-12
- FDA Inspection 801709 - 2012-09-28
- FDA Inspection 608319 - 2009-05-06

## Related Officers

- [Marijo B. Kambere](https://www.keypedia.com/people/marijo-b-kambere/54e010f0-0d56-4b20-b5e2-112e372de58b)

Company: https://www.keypedia.com/companies/ningxia-qiyuan-pharmaceutical-co-ltd/c3f60fce-9615-4bb0-96fb-7df0b3242164

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
